Both in Pharmaceuticals
Spyre Therapeutics vs BioMarin Pharmaceuticals
Over the past year SYRE returned +304.8% and BMRN returned +4.7%; their daily moves had a correlation of 0.23.
SYRE +304.8% BMRN +4.7%Growth of $1, one year, split-adjusted
| Metric | SYRE | BMRN |
|---|---|---|
| Price | $99.75 | $56.00 |
| Market cap | $9.32B | $10.84B |
| Today | +0.71% | +1.17% |
| 1 month | +17.7% | −6.5% |
| 6 months | +38.8% | +3.3% |
| Year to date | +204.5% | −5.8% |
| 1 year | +306.0% | +6.3% |
| Revenue growth (YoY) | — | +19.9% |
| Gross margin | — | 79.5% |
| Net margin | — | 4.5% |
| P/E (TTM) | — | 148.6× |
| Price / sales | — | 3.2× |
| Net cash | $1.15B | -$3.31B |
| Dividend yield | — | — |
| Volatility (60d) | 58.5% | 31.3% |
| Short % of float | 15.6% | 6.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).